ポリメラーゼ連鎖反応（PCR）分子診断の世界市場レポート 2025年

ポリメラーゼ連鎖反応（PCR）分子診断市場規模は、今後数年間で力強い成長が見込まれます。2029年の年間平均成長率（CAGR）は8.7％で、136億4,000万米ドルに成長します。予測期間の成長は、がん罹患率の増加、個別化医療に対する需要の高まり、分子診断学への投資の増加、迅速診断検査に対するニーズの高まり、非侵襲的出生前検査の需要拡大などに起因すると考えられます。この期間に予想される主な動向には、診断技術の発展、ポイント・オブ・ケアポリメラーゼ連鎖反応システムの開発、マルチプレックスポリメラーゼ連鎖反応の革新、ポリメラーゼ連鎖反応とマイクロ流体工学の統合、デジタルポリメラーゼ連鎖反応プラットフォームの技術強化などがあります。

感染症の流行の増加は、ポリメラーゼ連鎖反応（PCR）分子診断市場の拡大を促進すると予想されます。感染症は、細菌、ウイルス、真菌、寄生虫などの有害な微生物によって引き起こされ、人から人へ直接または間接的に広がる可能性があります。これらの疾患の蔓延が増加しているのは、抗生物質耐性の病原体の増加が主な原因であり、治療や制御がより困難になり、病気の長期化、医療費の増大、公衆衛生リスクの増大につながります。PCR分子診断法は、遺伝子レベルでの迅速かつ正確な病原体の検出を可能にすることで、感染症の管理を改善し、早期診断と的を絞った治療を可能にします。これにより、タイムリーな介入を促進し、感染の拡大を抑え、患者ケアを改善することで、ヘルスケアの成果が向上します。例えば、2023年11月、米国政府機関である保健福祉省は、2022年に新たに報告された慢性B型肝炎患者は2021年に比べて11％増加したと報告しました。その結果、感染症の流行の高まりがPCR分子診断市場の成長を後押ししています。

ポリメラーゼ連鎖反応（PCR）分子診断市場の主要企業は、検査効率とアクセシビリティを向上させるため、ベンチトップ型装置などの最先端ソリューションの開発に注力しています。ベンチトップ型装置は、作業台やテーブルに収まるほど小型の実験室グレードの装置で、科学、医療、工業用の検査や分析用に設計されています。例えば、2024年9月、ドイツに本拠を置くバイオテクノロジー企業であるQIAGEN N.V.は、臨床腫瘍学検査用のQIAcuityDx Digital PCR Systemを発表しました。このシステムは、パーティショニング、サーモサイクル、イメージングを1台の装置に統合し、完全自動化、ウォークアウェイ処理を特徴としています。DNAとRNAの絶対定量を約2時間で、最小限の操作時間で行うことができます。このシステムは、マルチプレキシングと連続的なナノプレート負荷のために最大5つの検出チャンネルをサポートし、検証済みと柔軟な研究モードの両方を提供することで、さまざまな臨床および研究所の要件に適応できます。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、貿易戦争と関税、そしてコロナ禍と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界のポリメラーゼ連鎖反応（PCR）分子診断PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界のポリメラーゼ連鎖反応（PCR）分子診断市場：成長率分析
• 世界のポリメラーゼ連鎖反応（PCR）分子診断市場の実績：規模と成長, 2019-2024
• 世界のポリメラーゼ連鎖反応（PCR）分子診断市場の予測：規模と成長, 2024-2029, 2034F
• 世界のポリメラーゼ連鎖反応（PCR）分子診断総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のポリメラーゼ連鎖反応（PCR）分子診断市場：製品タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 機器
• 試薬および消耗品
• ソフトウェア
• 世界のポリメラーゼ連鎖反応（PCR）分子診断市場：技術別、実績と予測, 2019-2024, 2024-2029F, 2034F
• リアルタイムポリメラーゼ連鎖反応
• デジタルポリメラーゼ連鎖反応
• 従来のポリメラーゼ連鎖反応
• 世界のポリメラーゼ連鎖反応（PCR）分子診断市場：サンプルタイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 血液サンプル
• 唾液サンプル
• 組織サンプル
• 尿サンプル
• 世界のポリメラーゼ連鎖反応（PCR）分子診断市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 感染症検査
• 腫瘍学検査
• その他の用途
• 世界のポリメラーゼ連鎖反応（PCR）分子診断市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• 診断検査室
• その他のエンドユーザー
• 世界のポリメラーゼ連鎖反応（PCR）分子診断市場、機器、タイプ別サブセグメンテーション：実績と予測, 2019-2024, 2024-2029F, 2034F
• 標準的なポリメラーゼ連鎖反応システム
• デジタルポリメラーゼ連鎖反応システム
• リアルタイムポリメラーゼ連鎖反応システム
• 世界のポリメラーゼ連鎖反応（PCR）分子診断市場、試薬および消耗品、タイプ別サブセグメンテーション：実績と予測, 2019-2024, 2024-2029F, 2034F
• ポリメラーゼ連鎖反応キット
• ポリメラーゼ連鎖反応酵素
• ポリメラーゼ連鎖反応プライマーとプローブ
• ポリメラーゼ連鎖反応マスターミックス
• 世界のポリメラーゼ連鎖反応（PCR）分子診断市場、ソフトウェア、タイプ別サブセグメンテーション：実績と予測, 2019-2024, 2024-2029F, 2034F
• ポリメラーゼ連鎖反応解析ソフトウェア
• データ管理ソフトウェア

第7章 地域別・国別分析

• 世界のポリメラーゼ連鎖反応（PCR）分子診断市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のポリメラーゼ連鎖反応（PCR）分子診断市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• ポリメラーゼ連鎖反応（PCR）分子診断市場：競合情勢
• ポリメラーゼ連鎖反応（PCR）分子診断市場：企業プロファイル
  • F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Laboratory Corporation of America Holdings
• Agilent Technologies Inc.
• Grifols S.A.
• Illumina Inc.
• Endress+Hauser AG
• bioMereieux SA
• Sysmex Corporation
• Bio-Rad Laboratories Inc.
• QuidelOrtho Corporation
• PerkinElmer
• Eppendorf AG
• Tecan Group
• Takara Bio Inc.
• Biocartis NV
• Zymo Research Corporation

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• ポリメラーゼ連鎖反応（PCR）分子診断市場2029：新たな機会を提供する国
• ポリメラーゼ連鎖反応（PCR）分子診断市場2029：新たな機会を提供するセグメント
• ポリメラーゼ連鎖反応（PCR）分子診断市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Polymerase chain reaction (PCR) molecular diagnostics is a laboratory method used to amplify and examine specific sequences of deoxyribonucleic acid or ribonucleic acid in a sample. Its primary function is to detect the presence of targeted genetic material, allowing for the identification of pathogens, genetic conditions, or mutations. This technique is extensively utilized in medical diagnostics due to its high sensitivity and accuracy in detecting infectious diseases, genetic disorders, and cancer-related markers.

The key product categories in PCR molecular diagnostics include instruments, reagents and consumables, and software. Instruments are devices or tools specifically designed for performing scientific, medical, or technical tasks and measurements. The technology includes real-time PCR, digital PCR, and conventional PCR methods, applied to various sample types such as blood, saliva, tissue, and urine. PCR molecular diagnostics are used across different applications, including infectious disease testing and oncology testing, and serve a range of end-users such as hospitals, diagnostic laboratories, and other healthcare facilities.

The polymerase chain reaction molecular diagnostics market research report is one of a series of new reports from The Business Research Company that provides polymerase chain reaction molecular diagnostics market statistics, including the polymerase chain reaction molecular diagnostics industry's global market size, regional shares, competitors with the polymerase chain reaction molecular diagnostics market share, detailed polymerase chain reaction molecular diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the polymerase chain reaction molecular diagnostics industry. This polymerase chain reaction molecular diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The polymerase chain reaction molecular diagnostics market size has grown strongly in recent years. It will grow from $8.97 billion in 2024 to $9.78 billion in 2025 at a compound annual growth rate (CAGR) of 9.0%. The growth during the historic period can be attributed to the rising demand for early disease detection, a growing prevalence of infectious diseases, heightened awareness of genetic disorders, increased adoption of point-of-care testing, and a higher incidence of chronic illnesses.

The polymerase chain reaction molecular diagnostics market size is expected to see strong growth in the next few years. It will grow to $13.64 billion in 2029 at a compound annual growth rate (CAGR) of 8.7%. The growth in the forecast period can be attributed to the increasing prevalence of cancer, rising demand for personalized medicine, growing investments in molecular diagnostics, increasing need for rapid diagnostic tests, and expanding demand for non-invasive prenatal testing. Key trends expected during this period include advancements in diagnostic technologies, development of point-of-care polymerase chain reaction systems, innovations in multiplex polymerase chain reaction, integration of polymerase chain reaction with microfluidics, and technological enhancements in digital polymerase chain reaction platforms.

The growing prevalence of infectious diseases is expected to drive the expansion of the polymerase chain reaction (PCR) molecular diagnostics market. Infectious diseases are caused by harmful microorganisms, such as bacteria, viruses, fungi, or parasites, which can spread directly or indirectly from person to person. The increasing prevalence of these diseases is largely due to the rise of antibiotic-resistant pathogens, which are more difficult to treat and control, leading to prolonged illness, higher healthcare costs, and greater public health risks. PCR molecular diagnostics improve the management of infectious diseases by offering rapid and accurate pathogen detection at the genetic level, enabling early diagnosis and targeted treatment. This enhances healthcare outcomes by promoting timely interventions, reducing the spread of infections, and improving patient care. For example, in November 2023, the Department of Health and Human Services, a U.S. government agency, reported an 11% increase in newly reported chronic hepatitis B cases in 2022 compared to 2021. As a result, the rising prevalence of infectious diseases is fueling the growth of the PCR molecular diagnostics market.

Leading companies in the polymerase chain reaction (PCR) molecular diagnostics market are focusing on developing cutting-edge solutions, such as benchtop instruments, to improve testing efficiency and accessibility. Benchtop instruments are compact, laboratory-grade devices small enough to fit on a workbench or table, designed for scientific, medical, or industrial testing and analysis. For example, in September 2024, QIAGEN N.V., a Germany-based biotechnology company, introduced the QIAcuityDx Digital PCR System for clinical oncology testing. This system features fully automated, walk-away processing, integrating partitioning, thermocycling, and imaging into a single instrument. It provides absolute quantification of DNA and RNA in about two hours, with minimal hands-on time. The system supports up to five detection channels for multiplexing and continuous nanoplate loading, offering both validated and flexible research modes, making it adaptable to various clinical and laboratory requirements.

In May 2024, Bruker Corporation, a U.S.-based manufacturer of high-end analytical instruments, acquired ELITechGroup for $930.9 million. This acquisition allows Bruker to enhance its presence in infectious disease diagnostics by broadening its molecular diagnostic capabilities and product portfolio, enabling it to better serve clinical laboratories and hospitals worldwide. ELITech Group SAS is an Italy-based in-vitro diagnostics company, specializing in polymerase chain reaction (PCR) molecular diagnostics.

Major players in the polymerase chain reaction molecular diagnostics market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Becton Dickinson and Company, Laboratory Corporation of America Holdings, Agilent Technologies Inc., Grifols S.A., Illumina Inc., Endress + Hauser AG, bioMereieux SA, Sysmex Corporation, Bio-Rad Laboratories Inc., QuidelOrtho Corporation, PerkinElmer, Eppendorf AG, Tecan Group, Takara Bio Inc., Biocartis NV, and Zymo Research Corporation.

North America was the largest region in the polymerase chain reaction molecular diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in polymerase chain reaction molecular diagnostics report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the polymerase chain reaction molecular diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The polymerase chain reaction molecular diagnostics market consists of revenues earned by entities by providing services such as infectious disease testing, genetic disorder screening, pharmacogenomics testing, deoxyribonucleic acid amplification services, and viral load monitoring. The market value includes the value of related goods sold by the service provider or included within the service offering. The polymerase chain reaction molecular diagnostics market also includes sales of thermal cyclers, electrophoresis systems, assay kits, and reverse transcriptase enzymes. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Polymerase Chain Reaction Molecular Diagnostics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on polymerase chain reaction molecular diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for polymerase chain reaction molecular diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The polymerase chain reaction molecular diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product Type: Instrument; Reagents And Consumables; Software
• 2) By Technology: Real-Time Polymerase Chain Reaction; Digital Polymerase Chain Reaction; Conventional Polymerase Chain Reaction
• 3) By Sample Type: Blood Samples; Saliva Samples; Tissue Samples; Urine Samples
• 4) By Application: Infectious Disease Testing; Oncology Testing; Other Applications
• 5) By End-User: Hospitals; Diagnostic Laboratories; Other End Users
• Subsegments:
• 1) By Instrument: Standard Polymerase Chain Reaction Systems; Digital Polymerase Chain Reaction Systems; Real-Time Polymerase Chain Reaction Systems
• 2) By Reagents And Consumables: Polymerase Chain Reaction Kits; Polymerase Chain Reaction Enzymes; Polymerase Chain Reaction Primers and Probes; Polymerase Chain Reaction Master Mix
• 3) By Software: Polymerase Chain Reaction Analysis Software; Data Management Software
• Companies Mentioned: F. Hoffmann-La Roche AG; Thermo Fisher Scientific Inc.; Abbott Laboratories; Danaher Corporation; Becton Dickinson and Company
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Polymerase Chain Reaction Molecular Diagnostics Market Characteristics

3. Polymerase Chain Reaction Molecular Diagnostics Market Trends And Strategies

4. Polymerase Chain Reaction Molecular Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Polymerase Chain Reaction Molecular Diagnostics Growth Analysis And Strategic Analysis Framework

• 5.1. Global Polymerase Chain Reaction Molecular Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Polymerase Chain Reaction Molecular Diagnostics Market Growth Rate Analysis
• 5.4. Global Polymerase Chain Reaction Molecular Diagnostics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Polymerase Chain Reaction Molecular Diagnostics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Polymerase Chain Reaction Molecular Diagnostics Total Addressable Market (TAM)

6. Polymerase Chain Reaction Molecular Diagnostics Market Segmentation

• 6.1. Global Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Instrument
• Reagents And Consumables
• Software
• 6.2. Global Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Real-Time Polymerase Chain Reaction
• Digital Polymerase Chain Reaction
• Conventional Polymerase Chain Reaction
• 6.3. Global Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Blood Samples
• Saliva Samples
• Tissue Samples
• Urine Samples
• 6.4. Global Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Infectious Disease Testing
• Oncology Testing
• Other Applications
• 6.5. Global Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By EndUser, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Diagnostic Laboratories
• Other End Users
• 6.6. Global Polymerase Chain Reaction Molecular Diagnostics Market, Sub-Segmentation Of Instrument, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Standard Polymerase Chain Reaction Systems
• Digital Polymerase Chain Reaction Systems
• Real-Time Polymerase Chain Reaction Systems
• 6.7. Global Polymerase Chain Reaction Molecular Diagnostics Market, Sub-Segmentation Of Reagents And Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Polymerase Chain Reaction Kits
• Polymerase Chain Reaction Enzymes
• Polymerase Chain Reaction Primers And Probes
• Polymerase Chain Reaction Master Mix
• 6.8. Global Polymerase Chain Reaction Molecular Diagnostics Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Polymerase Chain Reaction Analysis Software
• Data Management Software

7. Polymerase Chain Reaction Molecular Diagnostics Market Regional And Country Analysis

• 7.1. Global Polymerase Chain Reaction Molecular Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Polymerase Chain Reaction Molecular Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Polymerase Chain Reaction Molecular Diagnostics Market

• 8.1. Asia-Pacific Polymerase Chain Reaction Molecular Diagnostics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Polymerase Chain Reaction Molecular Diagnostics Market

• 9.1. China Polymerase Chain Reaction Molecular Diagnostics Market Overview
• 9.2. China Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Polymerase Chain Reaction Molecular Diagnostics Market

• 10.1. India Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Polymerase Chain Reaction Molecular Diagnostics Market

• 11.1. Japan Polymerase Chain Reaction Molecular Diagnostics Market Overview
• 11.2. Japan Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Polymerase Chain Reaction Molecular Diagnostics Market

• 12.1. Australia Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Polymerase Chain Reaction Molecular Diagnostics Market

• 13.1. Indonesia Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Polymerase Chain Reaction Molecular Diagnostics Market

• 14.1. South Korea Polymerase Chain Reaction Molecular Diagnostics Market Overview
• 14.2. South Korea Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Polymerase Chain Reaction Molecular Diagnostics Market

• 15.1. Western Europe Polymerase Chain Reaction Molecular Diagnostics Market Overview
• 15.2. Western Europe Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Polymerase Chain Reaction Molecular Diagnostics Market

• 16.1. UK Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Polymerase Chain Reaction Molecular Diagnostics Market

• 17.1. Germany Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Polymerase Chain Reaction Molecular Diagnostics Market

• 18.1. France Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Polymerase Chain Reaction Molecular Diagnostics Market

• 19.1. Italy Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Polymerase Chain Reaction Molecular Diagnostics Market

• 20.1. Spain Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Polymerase Chain Reaction Molecular Diagnostics Market

• 21.1. Eastern Europe Polymerase Chain Reaction Molecular Diagnostics Market Overview
• 21.2. Eastern Europe Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Polymerase Chain Reaction Molecular Diagnostics Market

• 22.1. Russia Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Polymerase Chain Reaction Molecular Diagnostics Market

• 23.1. North America Polymerase Chain Reaction Molecular Diagnostics Market Overview
• 23.2. North America Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Polymerase Chain Reaction Molecular Diagnostics Market

• 24.1. USA Polymerase Chain Reaction Molecular Diagnostics Market Overview
• 24.2. USA Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Polymerase Chain Reaction Molecular Diagnostics Market

• 25.1. Canada Polymerase Chain Reaction Molecular Diagnostics Market Overview
• 25.2. Canada Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Polymerase Chain Reaction Molecular Diagnostics Market

• 26.1. South America Polymerase Chain Reaction Molecular Diagnostics Market Overview
• 26.2. South America Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Polymerase Chain Reaction Molecular Diagnostics Market

• 27.1. Brazil Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Polymerase Chain Reaction Molecular Diagnostics Market

• 28.1. Middle East Polymerase Chain Reaction Molecular Diagnostics Market Overview
• 28.2. Middle East Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Polymerase Chain Reaction Molecular Diagnostics Market

• 29.1. Africa Polymerase Chain Reaction Molecular Diagnostics Market Overview
• 29.2. Africa Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Polymerase Chain Reaction Molecular Diagnostics Market Competitive Landscape And Company Profiles

• 30.1. Polymerase Chain Reaction Molecular Diagnostics Market Competitive Landscape
• 30.2. Polymerase Chain Reaction Molecular Diagnostics Market Company Profiles
  • 30.2.1. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis

31. Polymerase Chain Reaction Molecular Diagnostics Market Other Major And Innovative Companies

• 31.1. Laboratory Corporation of America Holdings
• 31.2. Agilent Technologies Inc.
• 31.3. Grifols S.A.
• 31.4. Illumina Inc.
• 31.5. Endress + Hauser AG
• 31.6. bioMereieux SA
• 31.7. Sysmex Corporation
• 31.8. Bio-Rad Laboratories Inc.
• 31.9. QuidelOrtho Corporation
• 31.10. PerkinElmer
• 31.11. Eppendorf AG
• 31.12. Tecan Group
• 31.13. Takara Bio Inc.
• 31.14. Biocartis NV
• 31.15. Zymo Research Corporation

32. Global Polymerase Chain Reaction Molecular Diagnostics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Polymerase Chain Reaction Molecular Diagnostics Market

34. Recent Developments In The Polymerase Chain Reaction Molecular Diagnostics Market

35. Polymerase Chain Reaction Molecular Diagnostics Market High Potential Countries, Segments and Strategies

• 35.1 Polymerase Chain Reaction Molecular Diagnostics Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Polymerase Chain Reaction Molecular Diagnostics Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Polymerase Chain Reaction Molecular Diagnostics Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer